156 related articles for article (PubMed ID: 36835839)
1. Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant.
Costanzo E; Giannini D; De Geronimo D; Fragiotta S; Varano M; Parravano M
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835839
[TBL] [Abstract][Full Text] [Related]
2. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
3. SUSPENDED SCATTERING PARTICLES IN MOTION MAY INFLUENCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VESSEL DENSITY METRICS IN EYES WITH DIABETIC MACULAR EDEMA.
Maltsev DS; Kulikov AN; Kazak AA; Freund KB
Retina; 2021 Jun; 41(6):1259-1264. PubMed ID: 33165296
[TBL] [Abstract][Full Text] [Related]
4. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.
Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S
Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333
[TBL] [Abstract][Full Text] [Related]
5. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
Eandi CM; De Geronimo D; Giannini D; Polito MS; Tosi GM; Neri G; Le Mer Y; Varano M; Parravano M
Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
[TBL] [Abstract][Full Text] [Related]
6. Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers.
Vujosevic S; Toma C; Villani E; Brambilla M; Torti E; Leporati F; Muraca A; Nucci P; De Cilla S
Transl Vis Sci Technol; 2020 Sep; 9(10):31. PubMed ID: 33062394
[TBL] [Abstract][Full Text] [Related]
7. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
Hsieh YT; Alam MN; Le D; Hsiao CC; Yang CH; Chao DL; Yao X
Ophthalmol Retina; 2019 Oct; 3(10):826-834. PubMed ID: 31227330
[TBL] [Abstract][Full Text] [Related]
8. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants.
Huang YT; Chang YC; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Tsai YY
Front Med (Lausanne); 2022; 9():852022. PubMed ID: 35755055
[TBL] [Abstract][Full Text] [Related]
9. Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema.
Qin S; Zhang C; Qin H; Xie H; Luo D; Qiu Q; Liu K; Zhang J; Xu G; Zhang J
Front Physiol; 2021; 12():791442. PubMed ID: 35002773
[No Abstract] [Full Text] [Related]
10. Dilated retinal large vessels and capillaries associated with diabetic macular edema and photoreceptor loss respectively.
Lei J; Xu X; Chen L; Fan X; Abdelfattah NS
Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):1831-1837. PubMed ID: 33417093
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography angiography analysis of microvascular abnormalities and vessel density in treatment-naïve eyes with diabetic macular edema.
Braham IZ; Kaouel H; Boukari M; Ammous I; Errais K; Boussen IM; Zhioua R
BMC Ophthalmol; 2022 Nov; 22(1):418. PubMed ID: 36329416
[TBL] [Abstract][Full Text] [Related]
12. Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant.
Shi K; Sun X; Zhang J
Dis Markers; 2021; 2021():3510036. PubMed ID: 34691285
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant.
Castro-Navarro V; Monferrer-Adsuara C; Navarro-Palop C; Montero-Hernández J; Cervera-Taulet E
BMC Ophthalmol; 2022 Apr; 22(1):191. PubMed ID: 35473615
[TBL] [Abstract][Full Text] [Related]
14. Imaging Biomarkers of 1-Year Activity in Type 1 Macular Neovascularization.
Costanzo E; Parravano M; Giannini D; Borrelli E; Sacconi R; Querques G
Transl Vis Sci Technol; 2021 May; 10(6):18. PubMed ID: 34111264
[TBL] [Abstract][Full Text] [Related]
15. Optical Coherence Tomography Predictors of Favorable Functional Response in Naïve Diabetic Macular Edema Eyes Treated with Dexamethasone Implants as a First-Line Agent.
Meduri A; Oliverio GW; Trombetta L; Giordano M; Inferrera L; Trombetta CJ
J Ophthalmol; 2021; 2021():6639418. PubMed ID: 33833870
[TBL] [Abstract][Full Text] [Related]
16. Clinical and optical coherence tomography biomarkers as prognostic factors in dexamethasone intravitreal implant for diabetic macular edema.
Oliverio GW; Meduri A; Brancati VU; Ingrande I; De Luca L; Raimondo ED; Minutoli L; Aragona E; Aragona P
Eur J Ophthalmol; 2024 Feb; ():11206721241235242. PubMed ID: 38384119
[TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
18. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
[TBL] [Abstract][Full Text] [Related]
19. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
20. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
Hwang HS; Chae JB; Kim JY; Kim DY
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
